Skip to main content
Log in

Upregulation of survivin by HIV-1 Vpr

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

The human survivin gene belongs to the family of inhibitor of apoptosis proteins (IAP) and is involved in apoptosis inhibition and regulation of cell division. The survivin gene is the only member of the IAP family whose expression is known to be regulated through the cell cycle. Survivin expression reaches the highest levels during the G2/M transition and then is rapidly degraded during the G1 phase. Here we report that the human immunodeficiency virus type 1 (HIV-1) upregulates Survivin expression via survivin promoter transactivation. Vpr, an HIV-1 accessory protein that induces cell cycle arrest in G2/M, is necessary and sufficient for this effect. Blocking Vpr-induced G2/M arrest leads to elimination of the survivin promoter transactivation by Vpr. Our results suggest that Survivin may be actively involved in regulating cell viability during HIV-1 infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Clem RJ, Fechheimer M, Miller LK. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 1991; 254: 1388–1390.

    Google Scholar 

  2. Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 2001; 7: 542–547.

    Google Scholar 

  3. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33–42.

    Google Scholar 

  4. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917–921.

    Google Scholar 

  5. Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580–584.

    Google Scholar 

  6. Otaki M, Hatano M, Kobayashi K, Ogasawara T, Kuriyama, T, Tokuhisa T. Cell cycle-dependent regulation of TIAP/m-survivin expression. Biochim Biophys Acta 2000; 1493: 188–194.

    Google Scholar 

  7. Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci 2000; 113(Part 23): 4363–4371.

    Google Scholar 

  8. Wheatley SP, Carvalho A, Vagnarelli P, Earnshaw WC. INCENP is required for proper targeting of survivin to the centromeres and the anaphase spindle during mitosis. Curr Biol 2001; 11: 886–890.

    Google Scholar 

  9. Uren AG, Wong L, Pakusch M, et al. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 2000; 10: 1319–1328.

    Google Scholar 

  10. Speliotes EK, Uren A, Vaux D, Horvitz HR. The survivin-like C, elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone. Mol Cell 2000; 6: 211–223.

    Google Scholar 

  11. O'Connor DS, Grossman D, Plescia J, et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 2000; 97: 13103–13107.

    Google Scholar 

  12. Chen J, Wu W, Tahir SK, et al. Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia 2000; 2: 235–241.

    Google Scholar 

  13. Cohen EA, Terwilliger EF, Jalinoos Y, Proulx J, Sodroski JG, Haseltine WA. Identification of HIV-1 vpr product and function. J Acquir Immune Defic Syndr 1990; 3: 11–18.

    Google Scholar 

  14. Re F, Braaten D, Franke EK, Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol 1995; 69: 6859–6864.

    Google Scholar 

  15. Rogel ME, Wu LI, Emerman M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J Virol 1995; 69: 882–888.

    Google Scholar 

  16. Jowett JB, Planelles V, Poon B, Shah NP, Chen ML, Chen IS. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol 1995; 69: 6304–6313.

    Google Scholar 

  17. He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995; 69: 6705–6711.

    Google Scholar 

  18. Heinzinger NK, Bukinsky MI, Haggerty SA, et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 1994; 91: 7311–7315.

    Google Scholar 

  19. Stewart SA, Poon B, Jowett JB, Chen IS. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J Virol 1997; 71: 5579–5592.

    Google Scholar 

  20. Shostak LD, Ludlow J, Fisk J, et al. Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr. Exp Cell Res 1999; 251: 156–165.

    Google Scholar 

  21. Watanabe N, Yamaguchi T, Akimoto Y, Rattner JB, Hirano H, Nakauchi H. Induction of M-phase arrest and apoptosis after HIV-1 vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells. Exp Cell Res 2000; 258: 261–269.

    Google Scholar 

  22. Chang L, Chen C, Urlacher V, Lee T. Differential apoptosis effects of primate lentiviral vpr and vpx in mammalian cells. J Biomed Sci 2000; 7: 322–333.

    Google Scholar 

  23. Zhu Y, Gelbard HA, Roshal M, Pursell S, Jamieson BD, Planelles V. Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes. J Virol 2001; 75: 3791–3801.

    Google Scholar 

  24. Li F, Altieri DC. Transcriptional analysis of human survivin gene expression. Biochem J 1999; 344(Part 2): 305–311.

    Google Scholar 

  25. Kimpton J, Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated betagalactosidase gene. J Virol 1992; 66: 2232–2239.

    Google Scholar 

  26. Grossman D, Kim PJ, Schechner JS, Altieri DC. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA 2001; 98: 635–640.

    Google Scholar 

  27. Planelles V, Jowett JBM, Li QX, Xie Y, Hahn B, Chen ISY. Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J Virol 1996; 70: 2516–2524.

    Google Scholar 

  28. Planelles V, Haislip A, Withers-Ward ES, et al. A new reporter system for detection of retroviral infection. Gene Ther 1995; 2: 369–376.

    Google Scholar 

  29. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90: 8033–8037.

    Google Scholar 

  30. An DS, Morizono K, Li QX, Mao SH, Lu S, Chen IS. An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication. J Virol 1999; 73: 7671–7677.

    Google Scholar 

  31. Poon B, Jowett JB, Stewart SA, Armstrong RW, Rishton GM, Chen IS. Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of theDNAalkylating agent, nitrogen mustard. J Virol 1997; 71: 3961–3971.

    Google Scholar 

  32. Stivahtis GL, Soares MA, Vodicka MA, Hahn BH, Emerman M. Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology. J Virol 1997; 71: 4331–4338.

    Google Scholar 

  33. Goh WC, Rogel ME, Kinsey CM, et al. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo. Nat Med 1998; 4: 65–71.

    Google Scholar 

  34. Sawaya BE, Khalili K, Mercer WE, Denisova L, Amini S. Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J Biol Chem 1998; 273: 20052–20057.

    Google Scholar 

  35. Wang L, Mukherjee S, Jia F, Narayan O, Zhao LJ. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J Biol Chem 1995; 270: 25564–25569.

    Google Scholar 

  36. Vanitharani R, Mahalingam S, Rafaeli Y, et al. HIV-1 Vpr transactivates LTR-directed expression through sequences present within ?278 to ?176 and increases virus replication in vitro. Virology 2001; 289: 334–342.

    Google Scholar 

  37. Zwicker J, Lucibello FC, Wolfraim LA, et al. Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. Embo J 1995; 14: 4514–4522.

    Google Scholar 

  38. Conti L, Matarrese P, Varano B, et al. Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells. J Immunol 2000; 165: 3293–3300.

    Google Scholar 

  39. Tamm I, Wang Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58: 5315–5320.

    Google Scholar 

  40. Kornacker M, Verneris MR, Kornacker B, Scheffold C, Negrin RS. Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells. Immunol Lett 2001; 76: 169–173.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Planelles.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, Y., Roshal, M., Li, F. et al. Upregulation of survivin by HIV-1 Vpr. Apoptosis 8, 71–79 (2003). https://doi.org/10.1023/A:1021653119934

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021653119934

Navigation